0001019056-17-000547.txt : 20170601
0001019056-17-000547.hdr.sgml : 20170601
20170601213949
ACCESSION NUMBER: 0001019056-17-000547
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170601
FILED AS OF DATE: 20170601
DATE AS OF CHANGE: 20170601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamothe Jeffrey G.
CENTRAL INDEX KEY: 0001679967
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 17886315
MAIL ADDRESS:
STREET 1: 2401 4TH AVENUE
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
lamothe_4.xml
OWNERSHIP DOCUMENT
X0306
4
2017-06-01
0
0001671584
Aptevo Therapeutics Inc.
APVO
0001679967
Lamothe Jeffrey G.
2401 4TH AVENUE, SUITE 1050
SEATTLE
WA
98121
0
1
0
0
SVP, CFO and Treasurer
Employee Stock Option (right to buy)
2.15
2017-06-01
4
A
0
33700
0
A
2027-05-31
Common Stock
33700
33700
D
The option grant was approved by a committee of Aptevo Therapeutics Inc.'s board of directors on February 22, 2017, subject to stockholder approval of the Amended and Restated 2016 Stock Incentive Plan (the "Plan") under which the option was granted. Aptevo Therapeutics Inc.'s stockholders approved the Plan on May 31, 2017.
The option vests in three equal annual installments beginning on June 1, 2018.
/s/ Benjamin J. Stein, attorney-in-fact
2017-06-01